MyRemD
Research & validation

We say what we know. And what we don't.

MyRemD is evidence-informed, not evidence-inflated. Our research program is public, honest and paced to the reality of clinical validation.

Research philosophy

Rigor before reach.

We would rather ship less, more carefully, than more, more loudly. Sleep is life; the work deserves patience.

Evidence-first

Every surface traces to published behavioral sleep medicine.

Transparent

We label evidence strength — strong, moderate, emerging, unknown.

Collaborative

Co-authored, not walled-off. Academic partners welcomed.

Evidence framework

Four levels of certainty.

Level 01

Strong evidence

Multiple randomized trials, meta-analyses, clinical guidelines.

Level 02

Moderate evidence

Consistent observational data or single high-quality trial.

Level 03

Emerging evidence

Early-stage studies, plausible mechanism, active investigation.

Level 04

Unknowns

Areas where evidence is thin. We say so, plainly.

Current priorities

Where we're looking now.

Engagement & adherence

Understanding what makes people stay with CBT-I longer.

Longitudinal patterns

How sleep rhythms shift across months and life stages.

Clinician workflow

Where prepared context improves the exam room.

Safety & guardrails

How companion AI should escalate to human care.

Validation roadmap

A public, honest roadmap.

  1. Phase 01
    Foundational evidence review

    Codify the CBT-I, stimulus control and circadian evidence base underlying every recommendation.

    In progress
  2. Phase 02
    Real-world engagement studies

    Measure adherence, retention and self-reported outcomes across early cohorts.

    Planned
  3. Phase 03
    Clinician-in-the-loop evaluations

    Structured evaluations with partner sleep clinics on shared context and prepared appointments.

    Planned
  4. Phase 04
    Peer-reviewed publications

    Co-authored publications with academic partners on longitudinal sleep behavior.

    Planned
  5. Phase 05
    Regulatory validation studies

    Prospective studies aligned with future software-as-medical-device pathways.

    Planned
Future clinical studies

Planned protocols

  • Longitudinal CBT-I adherence in real-world settingsPlanned
  • Chronotype detection accuracy from wearable signalPlanned
  • Prepared-appointment impact on sleep clinic throughputPlanned
  • Behavioral change durability at 6 and 12 monthsPlanned
Academic collaborations

Partner institutions

We are in early conversations with academic medical centers and university sleep programs. Named partnerships will be announced only after formal agreements.

Institution 01
Future partner
TBA
Institution 02
Future partner
TBA
Institution 03
Future partner
TBA
Institution 04
Future partner
TBA
Publications

Peer-reviewed work

No publications yet. Our first co-authored manuscripts are in preparation with partner institutions.
In preparation
Conference presentations

Talks & posters

MyRemD plans to share early results at SLEEP, WorldSleep and academic sleep medicine conferences as data becomes available.
Planned
Data governance

Consent, clarity, control.

Research data is consented, de-identified where possible, and governed by IRB/ethics review for any study involving human subjects. Patients hold their data; participation is always opt-in.

Consent

Explicit, revocable, per-study opt-in.

De-identification

Minimum necessary data, aggregated by default.

Oversight

IRB/ethics review for human-subjects research.

See our Trust Center for the full data & security posture.
Research participation

Interested in collaborating?

Investigators, PhD candidates, and clinical research teams are welcome to reach out.